Hippotherapy in Patients With Schizophrenia (NCT06303596) | Clinical Trial Compass
UnknownNot Applicable
Hippotherapy in Patients With Schizophrenia
Turkey (Türkiye)88 participantsStarted 2024-03-20
Plain-language summary
This study will determine the efficacy of hippotherapy (horseback-riding) program, as an adjuvant to standard psychiatric treatment, on the outcomes of patients with schizophrenia. A randomized controlled trial is conducted in a Community Mental Health Center. All participants are randomized into two groups (experimental and control groups) using blocked randomization. All participants received the standard psychiatric treatment, while the experimental group is additionally provided with a 16-session hippotherapy program for 8 weeks. All participants will be evaluated using the Positive and Negative Syndrome Scale, State-Trait Anxiety Inventory, Quality of Life Scale, UCLA Loneliness Scale at both baseline and after the intervention.
Who can participate
Age range
19 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Being diagnosed with schizophrenia,
* Being at an age of older than 18 years,
* Being registered with and treated at the Community Mental Health Center,
* Being at remission period (a stable condition) at the time of enrollment and throughout the study.
* Being able to provide written informed consent and comprehend the instruments.
Exclusion Criteria:
* The participants who suffer from other comorbid psychiatric disorders (depression, personality disorder, substance addiction, etc.),
* The participants who are not willing to sign the consent.
* The participants who have physical health problems that would prevent horseback-riding.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
The Positive and Negative Syndrome Scale (PANSS)
Timeframe: For two study groups: at pre-intervention and immediately after the intervention.
2
State-Trait Anxiety Inventory (STAI)
Timeframe: For two study groups: at pre-intervention and immediately after the intervention.
3
The Quality of Life Scale (QLS)
Timeframe: For two study groups: at pre-intervention and immediately after the intervention.
4
UCLA Loneliness Scale
Timeframe: For two study groups: at pre-intervention and immediately after the intervention.